Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Agilon Health Inc’s stock clocked out at $2.33, down -4.12% from its previous closing price of $2.43. In other words, the price has decreased by -$4.12 from its previous closing price. On the day, 2.63 million shares were traded. AGL stock price reached its highest trading level at $2.43 during the session, while it also had its lowest trading level at $2.28.
Ratios:
To gain a deeper understanding of AGL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 08, 2025, Bernstein Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $8.50.
Citigroup Upgraded its Sell to Neutral on January 10, 2025, whereas the target price for the stock was revised from $1.75 to $2.25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when McLoughlin Karen bought 25,000 shares for $2.20 per share. The transaction valued at 55,085 led to the insider holds 73,166 shares of the business.
Battaglia Silvana bought 25,062 shares of AGL for $50,269 on Dec 11 ’24. The Director now owns 66,144 shares after completing the transaction at $2.01 per share. On Nov 25 ’24, another insider, MCKENZIE DIANA, who serves as the Director of the company, bought 12,500 shares for $2.28 each. As a result, the insider paid 28,474 and bolstered with 51,319 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGL now has a Market Capitalization of 964508160 and an Enterprise Value of 627024064. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.16 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 0.105 whereas that against EBITDA is -2.278.
Stock Price History:
The Beta on a monthly basis for AGL is 0.16, which has changed by -0.5947826 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, AGL has reached a high of $7.73, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -12.71%, while the 200-Day Moving Average is calculated to be -23.59%.
Shares Statistics:
It appears that AGL traded 5.21M shares on average per day over the past three months and 3127950 shares per day over the past ten days. A total of 413.02M shares are outstanding, with a floating share count of 302.33M. Insiders hold about 26.96% of the company’s shares, while institutions hold 73.51% stake in the company. Shares short for AGL as of 1749772800 were 21228626 with a Short Ratio of 4.07, compared to 1747267200 on 22198808. Therefore, it implies a Short% of Shares Outstanding of 21228626 and a Short% of Float of 8.3900005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
